FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377494000: Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202813012 Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1475927017 Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5mg/1.6mg suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1476888019 Hydrocortisone+neomycin sulfate+polymyxin b sulfate 10mg/5mg/1.6mg suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Product containing hydrocortisone (medicinal product) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Compound neomycin preparations false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Hydrocortisone-containing product in otic dose form false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Product containing polymyxin B (medicinal product) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B (substance) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin (substance) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B sulfate false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrocortisone (substance) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anti-infectieux cutané false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulfate false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Has manufactured dose form Otic dose form (dose form) false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Polymyxin B-containing product in otic dose form false Inferred relationship Some
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Is a Product containing neomycin in otic dose form (medicinal product form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start